TRVI · Trevi Therapeutics, Inc.
Market Cap
$2.46B
Shares
142.48M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1563880
CUSIP
89532M101
13F (30d)
153 filings
153 filers
Visit website
Investor relations